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Abstract
Background:  The serum marker Procalcitonin (PCT) has been 
shown to be a sensitive indicator of bacterial infection, but very lit-
tle is known of its behavior in periprosthetic infection. In this study, 
PCT was compared with standard tests used to aid the diagnosis of 
infection. As a baseline, its pattern in uncomplicated hip and knee 
arthroplasty was investigated.
Methods:  A prospective study of fifty- nine patients had bloods 
taken preoperatively, and on days 1, 3, 5, for PCT, C- reactive pro-
tein, erythrocyte sedimentation rate and white cell count.
Results:  Fifty patients (85%) had normal PCT values (< 0.5 ng/ml) 
and only 5 recorded a value >1.0ng/ml. On day 5 only 1 patient had 
a value > 0.5ng/ml. The standard tests all showed sporadic eleva-
tions over the 3 days. PCT levels are not significantly elevated by 
the trauma of this surgery, as they are in other surgical procedures.
Conclusions:  PCT may be very useful in patients with suspected 
periprosthetic infection.
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Introduction
  Two of the major complications of total knee and hip 
joint  arthroplasty  is  peri-prosthetic  infection  and  aseptic 
loosening.  Many  studies  have  investigated  means  of  dif-
ferentiating the two, mainly because the approach to revi-
sion arthroplasty and prognosis differs significantly between 
them.  However,  the  diagnosis  of  peri-prosthetic  infection 
still remains a difficult diagnosis [1].
  Part of the explanation for this is the lack of reliability 
of the commonly used blood tests- C-reactive protein (CRP), 
erythrocyte sedimentation rate (ESR) and white cell count 
(WCC). A  spectrum  of  inflammation  naturally  occurs  in 
response to the tissue injury caused by surgery, commonly 
named the acute phase response. It has been shown that these 
blood parameters lack sensitivity and specificity in discrimi-
nating the inflammation of infection per se from that of the 
acute phase response [2-7].
  Since  the  early  1990s  there  has  been  much  interest 
addressing whether procalcitonin (PCT) is a more specific 
marker in detecting early bacterial infection in the periop-
erative period. Although they have often given conflicting 
results, it is largely believed that PCT is a more accurate 
indicator of infection [8-10]. PCT is a precursor of the hor-
mone calcitonin, and is detectable in the serum of healthy 
individuals at a concentration of less than 0.5 ng/ml. Bacte-
rial endotoxin has been shown to directly release PCT into 
the circulation [11, 12].
  However, it is also elevated by the acute phase response 
[8], and this has resulted in much debate in the literature as 
to what cut-off value should represent infection [3, 13]. This 
has caused ambiguous conclusions in different studies re-
garding the superiority of PCT. This has been largely seen 
in abdominal and cardiothoracic surgery, as well as intensive 
care medicine. This is partly because these operations com-
monly cause a severe inflammatory response – including the 
Systemic Inflammatory Response Syndrome-in non-infec-
tious cases [8, 14-16].
  Very few studies have looked at PCT in orthopaedics, 
and have only included small subgroups of patients in groups 
of patients undergoing different types of surgery [17]. Thus it 
appeared worthwhile to perform a study looking specifically 
at the characteristics of PCT in orthopaedic surgery. The aim 
of this study is therefore twofold: to illustrate the pattern of 
PCT in comparison to the routine inflammatory markers and, 
from this, to show if PCT could have a clinical role in peri-
prosthetic infection.
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Materials and Methods
   A prospective study over 6 months of fifty-nine patients 
undergoing either primary total hip or knee arthroplasty was 
performed. The mean age was 70.5 years, involving 19 men 
and 40 women. There were no exclusion criteria, and the 
study was sponsored by NHS Argyll and Clyde. Written in-
formed consent was obtained. Prophylactic cefuroxime was 
given at induction of anesthesia followed by 2 post-operative 
doses. 
 Serum blood samples for PCT, CRP, ESR and WCC 
were taken pre-operatively and on days 1, 3 and 5 post-oper-
atively. Blood pressure, pulse, respiratory rate and tempera-
ture were also recorded on these days. None of the patients 
showed any clinical sign of infection during their stay in 
hospital.
        Hospital records were reviewed after their routine 
6 week follow-up appointments. All the patients had been 
subsequently referred to the nurse lead arthroplasty clinic, 
indicating no clinical suspicion of infection.
The data was analysed by a statistician. PCT was mea-
sured using the Lumitest PCT-Q (Brahms Diagnostica, Ger-
many).
 
Results
The descriptive statistics of the measured variables are 
shown in Tables 1 and 2.
PCT
  Fifty patients (85%) had concentrations of PCT with-
in the normal range (< 0.5 ng/ml) on all four days. In the 
remaining nine patients there was no significant day of oc-
Variable          Mean          St Dev             Minimum           Q1           Median           Q3              Maximum
AVE PCT        0.5096          1.117               0.3                       0.3            0.3                  0.3              10
AVE CRP        87.28            61.02               10                        39             83                  121              292
AVE ESR        51.36            31.37               4                          25.5          48                   77               125
AVE WCC      9.672            2.579               4.6                        7.75         9.5                  11.1             18.3
Table 1. Descriptive statistics of the average values for the parameters over the 3 post-operative days
Variable           Mean           St Dev             Minimum       Q1              Median             Q3                   Maximum
Day 0 PCT        0.3797          0.6119            0.3                    0.3              0.3                     0.3                    5
Day 1 PCT        0.4051          0.3496            0.3                    0.3              0.3                     0.3                    2
Day 3 PCT        0.798           1.877               0.3                    0.3              0.3                     0.3                   10
Day 5 PCT        0.3254         0.1027             0.3                    0.3              0.3                     0.3                   1
Day 0 CRP       11.78             9.64                2                       10              10                       10                    62
Day 1 CRP        75.32           47.22              12                      38              66                       98                    189
Day 3 CRP        129.02          62.44              10                     91              120                    162                   292
Day 5 CRP        57.49            48.47              10                     20              46                       91                    280
Day 0 ESR        20.76           17.33               4                       7                14                       26                    77
Day 1 ESR        31.42           25.59               4                       13              25                       42                    121
Day 3 ESR        62.56           30.48               4                       41              59                       88                    125
Day 5 ESR        60.1             28.16               4                       42              52                       82                    122
Day 0 WCC      7.731            2.329              3.4                    6.1             7.8                      9                      17.5
Day 1 WCC      10.261          2.842               5                      8.3             10                       11.8                  18.3
Day 3 WCC      9.922            2.229               5.7                   7.9              9.8                     10.9                 18.3
Day 5 WCC      8.834            2.451               4.6                   7                 8.8                     10.2                 16.3
Table 2. Descriptive statistics for each parameter on all days
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currence of the maximum PCT level, and only five patients 
(8%) recorded a value > 1.0 ng/ml. Two patients had a value 
> 5 ng/ml. This was measured at 10 ng/ml on day 3. These 
patients had values of < 0.5 ng/ml on the other 3 days. One 
patient had a preoperative value > 0.5 ng/ml. Only 1 patient 
had a value > 0.5 ng/ml on day 5. The data is shown on Fig-
ure 1.
 
CRP, ESR and WCC
  Nine patients had a preoperative CRP value above the 
normal range (< 10 mg/l ). The day of occurrence of the max-
imum value was day 3 in 71% of patients, day 1 in 20% and 
day 5 in 9%. The maximum recorded value was 292 mg/l on 
day 3. This patient’s CRP was < 10 mg/l on day 5.
  Thirteen patients had an ESR above a reference range 
of 30 mm/hr preoperatively. Days 3 and 5 had an equal dis-
tribution of patient’s maximum values, (46% on each day).
 Two patients had a preoperative WCC >12000/mm3, 
and five patients (8%) had there maximum value on this day. 
Twenty nine (49%) had there maximum value on day 1, 34% 
on day 3 and 9% on day 5. This data is illustrated on Figures 
2-4.
Discussion
  
Procalcitonin  is  a  polypeptide  prohormone  of  calci-
tonin, mainly produced by the c-cells of the thyroid (8). It 
was initially described as a possible marker of infection in 
1993 [18]. Since then there has been growing interest in the 
question of whether is a more specific marker of bacterial 
infection. Although it gas been shown to respond directly 
to bacterial endotoxin [11, 12], it is also stimulated by non-
infective inflammation [8-10,14, 15, 19, 20]. This has caused 
conflicting opinion regarding its superiority in this matter. 
Unsurprisingly, many papers have drawn comparisons with 
CRP. A meta-analysis of such papers [9] concluded that PCT 
Figure 1. Concentrations of PCT. 
Figure 2. Changes of C-reactive protein.
Figure 3. Changes of erythrocyte sedimentation rate (ESR).
Figure 4. Changes of white cell count (WCC).
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was a more accurate marker of bacterial infection. However, 
many well designed studies have shown that PCT is no bet-
ter than CRP [21- 23].
   There is further dispute in surgery because the severity 
of the natural inflammatory response (acute phase response) 
depends upon the type of operation. There is much debate 
as to what cut-off value of PCT differentiates infection from 
the acute phase response [3, 13]. Most studies have been in 
cardio-thoracic and abdominal surgery where cut-off values 
vary from 1- 10 ng/ml during the perioperative period [5, 9, 
13, 15-17]. This is largely because these procedures com-
monly cause the systemic inflammatory response syndrome 
[8, 16, 24].
  None of the patients in this study developed systemic 
inflammatory response syndrome (SIRS). The results con-
vincingly show that hip and knee arthroplasty don’t cause 
a significant rise in PCT. Measurements for diagnostic pur-
poses are more helpful when the surgical trauma itself does 
not trigger considerable PCT release.
  It is also proposed that PCT is better than CRP in the 
perioperative period because secretions begin within 4 hours 
and peak at 8 hours. CRP peaks only after 36 hours [9, 25]. 
The behavior of CRP in hip and knee arthroplasty is well 
documented- a pronounced rise at day 2 or 3, followed by a 
sharp decline [25, 26]. These results show this pattern, sug-
gesting that this group is typical representation of other such 
studies. The results also indicate the limited use of ESR and 
WCC in this setting. Interestingly, nine patients (15%) had 
elevated CRP levels preoperatively. The only significance 
in their medical background was that three had previously 
undergone  either  hip  or  knee  arthroplasty. The  PCT  was 
normal in these patients. Further studies have looked into 
other serum markers, one such paper analysing interleukin-6 
in periprosthetic infection [2]. They had to exclude several 
patients because this test is elevated by chronic inflamma-
tory diseases. It would appear from this study that PCT isn’t 
affected in this way.
  In summary, PCT may be a more reliable indicator of 
periprosthetic infection given the substantial proportion of 
patients with unexplained high CRP levels preoperatively. 
Also, because the surgery doesn’t cause PCT to rise indi-
cates that it could be used to monitor high risk patients in 
the immediate post- operative period. This is further sup-
ported by its rapid elevation in infection, and the fact that 
the CRP, ESR and WCC are still elevated during this period. 
This would further imply that PCT would be useful in moni-
toring patients after their revision surgery for periprosthetic 
infection when it is often difficult to know if the infection 
has been eradicated [4, 7]. A large multicentre study involv-
ing patients undergoing revision surgery for infection needs 
to be performed to validate these findings and assumptions.
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